Does Agenerase Capsule Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- PROTEASE INHIBITORS/ORAL MIDAZOLAM; TRIAZOLAM
- SELECTED CYP3A4 INHIBITORS/PIMOZIDE
- PROTEASE INHIBITORS/ERGOT ALKALOIDS
- SELECTED CYP3A4 SUBSTRATES/RIFAMPIN
- PROTEASE INHIBITORS; COBICISTAT/ASTEMIZOLE; TERFENADINE
- SELECTED CYP3A4 SUBSTRATES/ST. JOHN'S WORT
- AMPRENAVIR-PROPYLENE GLYCOL/DISULFIRAM
- PROPYLENE GLYCOL/METRONIDAZOLE; TINIDAZOLE
- PROTEASE INHIBITORS/APALUTAMIDE
- SELECTED STRONG AND MODERATE CYP3A4 INHIBITORS/CISAPRIDE
- MODERATE CYP3A4 INHIBITORS/DARIDOREXANT (>25 MG)
- MODERATE CYP3A4 INHIBITORS/MITAPIVAT (> 20 MG)
- STRONG AND MODERATE CYP3A4 INHIBITORS/LONAFARNIB
- STRONG CYP3A4 INHIB; PROTEASE INHIB/LUMATEPERONE (>10.5 MG)
- SLT STRONG & MODERATE CYP3A4 INHIBITORS/CILOSTAZOL (>50MG)
- AMPRENAVIR; FOSAMPRENAVIR/SELECTED ANTIARRHYTHMICS
- STRONG AND MODERATE CYP3A4 INHIBITORS/ASUNAPREVIR
- STRONG OR MODERATE CYP3A4 INHIBITORS/LOMITAPIDE
- MODERATE CYP3A4 INHIBITORS/NALOXEGOL (> 12.5 MG)
- MODERATE CYP3A4 INHIBITORS/RANOLAZINE (> 500 MG BID)
- MODERATE CYP3A4 INHIBITORS/AVANAFIL (> 50 MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/FLIBANSERIN
- SELECTED STRONG AND MODERATE CYP3A4 INHIBITORS/DOMPERIDONE
- SELECTED PROTEASE INHIBITORS/ATORVASTATIN (>20 MG)
- HIV PROTEASE INHIBITORS; COBICISTAT/SILDENAFIL (FOR PAH)
- AMPRENAVIR; FOSAMPRENAVIR/DELAVIRDINE
- SELECTED PROTEASE INHIBITORS/VARDENAFIL (> 2.5 MG)
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/EPLERENONE
- SELECTED CYP3A4 INHIBITORS/LOVASTATIN; SIMVASTATIN
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED PROTEASE INHIBITORS/ALPRAZOLAM
- SELECTED PROTEASE INHIBITORS/NEVIRAPINE
- SELECTED PROTEASE INHIBITORS/CONTRACEPTIVES
- SELECTED PROTEASE INHIBITORS/RIFABUTIN; RIFAPENTINE
- PROTEASE INHIBITORS/CARBAMAZEPINE
- SELECTED PROTEASE INHIBITORS AND NNRTIS/GARLIC
- AMPRENAVIR; FOSAMPRENAVIR/TIPRANAVIR
- FOSAMPRENAVIR/ETRAVIRINE
- PROTEASE INHIBITORS/ENZALUTAMIDE
- ANTI-RETROVIRALS/ATIDARSAGENE AUTOTEMCEL
- ANTI-RETROVIRALS/LOVOTIBEGLOGENE AUTOTEMCEL
- STRONG AND MODERATE CYP3A4 INHIBITORS/NIROGACESTAT
- STRONG AND MODERATE CYP3A4 INHIBITORS/REPOTRECTINIB
- MODERATE CYP3A4 INHIBITORS/LURBINECTEDIN
- CYP3A4 INDUCERS/ERLOTINIB
- MODERATE CYP3A4 INHIBITORS/COLCHICINE (FOR CARDIOPROTECTION)
- MODERATE CYP3A4 INHIBITORS/OMAVELOXOLONE
- STRONG AND MODERATE CYP3A4 INHIBITORS/ELACESTRANT
- SELECT PROTEASE INHIBITORS; COBICISTAT/TADALAFIL (BPH)
- MODERATE CYP3A4 INHIBITORS/PEXIDARTINIB
- ANTI-RETROVIRALS/ELIVALDOGENE AUTOTEMCEL
- ANTI-RETROVIRALS; HYDROXYUREA/BETIBEGLOGENE AUTOTEMCEL
- PROTEASE INHIBITORS; COBICISTAT/TACROLIMUS
- MODERATE CYP3A4 INHIBITORS/MAVACAMTEN
- MODERATE CYP3A4 INHIBITORS/PACRITINIB
- MODERATE CYP3A4 INHIBITORS/MOBOCERTINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/FEXINIDAZOLE
- STRONG AND MODERATE CYP3A4 INHIBITORS/INFIGRATINIB
- MODERATE CYP3A4 INHIBITORS/VOCLOSPORIN
- STRONG AND MODERATE CYP3A4 INHIBITORS/PRALSETINIB
- MODERATE CYP3A4 INHIBITORS/SELPERCATINIB
- MODERATE CYP3A4 INHIBITORS/PEXIDARTINIB (200 MG)
- STRONG AND MODERATE CYP3A4 INHIBITORS/PEMIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/SELUMETINIB
- MODERATE CYP3A4 INHIBITORS/TAZEMETOSTAT
- CYP3A4 INDUCERS/LUMATEPERONE
- STRONG AND MODERATE CYP3A4 INHIBITORS/LEMBOREXANT
- MODERATE CYP3A4 INHIBITORS/ELEXACAFTOR-TEZACAFTOR-IVACAFTOR
- MODERATE CYP3A4 INHIBITORS/ENTRECTINIB
- PROTEASE INHIBITORS/QUETIAPINE
- MODERATE CYP3A4 INHIBITORS/BRIGATINIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/ENCORAFENIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/TEZACAFTOR-IVACAFTOR
- STRONG AND MODERATE CYP3A4 INHIBITORS/DEFLAZACORT
- MODERATE CYP3A4 INHIBITORS/VENETOCLAX
- MODERATE CYP3A4 INHIBITORS/NALOXEGOL (<= 12.5 MG)
- STRONG & MODERATE CYP3A4 INHIBITORS/ELIGLUSTAT
- MODERATE CYP3A4 INHIBITORS/SUVOREXANT (> 10 MG)
- STRONG & MODERATE CYP3A4 INHIBITORS/GUANFACINE
- STRONG OR MODERATE CYP3A4 INHIBITORS/SIMEPREVIR
- MODERATE CYP3A4 INHIBITORS/BOSUTINIB
- STRONG CYP3A4 INHIBITORS; AMPRENAVIR;ATAZANAVIR/MIFEPRISTONE
- STRONG AND MODERATE CYP3A4 INHIBITORS/IVACAFTOR
- COBICISTAT; PROTEASE INHIBITORS/SALMETEROL
- FOSAMPRENAVIR; RITONAVIR/ULIPRISTAL
- MODERATE CYP3A4 INHIBITORS/COLCHICINE
- PROTEASE INHIBITORS/BOSENTAN
- MODERATE CYP3A4 INHIBITORS/TOLVAPTAN
- AMPRENAVIR; DELAVIRDINE/IXABEPILONE
- SELECTED PROTEASE INHIBITORS/MARAVIROC
- PROTEASE INH;COBICISTAT/SLT IMMUNOSUPPRESSANTS;TEMSIROLIMUS
- MODERATE CYP3A4 INHIBITORS/IVABRADINE
- SELECTED CYP3A4 INHIBITORS/TRAZODONE
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- AMPRENAVIR; ATAZANAVIR/ANTACIDS; BUFFERED FORMULATIONS
- SELECTED PROTEASE INHIBITORS/LOPINAVIR
- SELECTED PROTEASE INHIBITORS/NIRMATRELVIR-RITONAVIR
- MODERATE CYP3A4 INHIBITORS/MACITENTAN
- MODERATE CYP3A4 INHIBITORS/FINERENONE
- MODERATE CYP3A4 INHIBITORS/CAPIVASERTIB
- STRONG AND MODERATE CYP3A4 INHIBITORS/ETRASIMOD
- MODERATE CYP3A4 INHIBITORS/GEPIRONE
- MODERATE CYP3A4 INHIBITORS/PALOVAROTENE
- MODERATE CYP3A4 INHIBITORS/LAROTRECTINIB
- SELECT PROTEASE INHIBITORS; COBICISTAT/TADALAFIL (PAH)
- STRONG CYP3A4 INHIB; PROTEASE INHIB/LUMATEPERONE (<=10.5 MG)
- MODERATE CYP3A4 INHIBITORS/MITAPIVAT (<= 20 MG)
- MODERATE CYP3A4 INHIBITORS/DARIDOREXANT (<=25 MG)
- ALCOHOL; PROPYLENE GLYCOL/SECNIDAZOLE
- PROTEASE INHIBITORS/SELECTED BENZODIAZEPINES
- STRONG OR MODERATE CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
- MODERATE CYP3A4 INHIBITORS/RIMEGEPANT
- MODERATE CYP3A4 INHIBITORS/AVAPRITINIB
- MODERATE CYP3A4 INHIBITORS/UBROGEPANT
- MODERATE CYP3A4 INHIBITORS/ZANUBRUTINIB
- MODERATE CYP3A4 INHIBITORS/ORAL LEFAMULIN
- FAT SOLUBLE VITAMINS/COLESEVELAM
- SELECTED PROTEASE INHIBITORS; COBICISTAT/LIDOCAINE
- STRONG CYP3A4 INHIBITORS; PROTEASE INHIBITORS/BREXPIPRAZOLE
- MODERATE CYP3A4 INHIBITORS/ABEMACICLIB
- SELECTED MODERATE CYP3A4 INHIBITORS/IVOSIDENIB
- SELECTED MODERATE CYP3A4 INHIBITORS/ACALABRUTINIB
- SELECTED CYP3A4 INHIBITORS/BROMOCRIPTINE; CABERGOLINE
- MODERATE CYP3A4 INHIBITORS/SUVOREXANT (<= 10 MG)
- MODERATE CYP3A4 INHIBITORS/AVANAFIL (<= 50 MG)
- MODERATE CYP3A4 INHIBITORS/IBRUTINIB
- SELECTED PROTEASE INHIBITORS/ATORVASTATIN (<= 20 MG)
- SELECTED MODERATE CYP3A4 INHIBITORS/SELECTED OPIOIDS
- SLT PROTEASE INHIB;COBICISTAT/SILDENAFIL (ED);TADALAFIL (ED)
- MODERATE CYP3A4; P-GP INHIBITORS/EVEROLIMUS
- MODERATE CYP3A4 INHIBITORS/RANOLAZINE (<=500 MG BID)
- FAT SOLUBLE VITAMINS/ORLISTAT
- AMPRENAVIR; FOSAMPRENAVIR/TRICYCLIC COMPOUNDS
- SELECTED PROTEASE INHIBITORS/SELECTED ANTIARRHYTHMICS
- SELECTED PROTEASE INHIBITORS/VARDENAFIL (<= 2.5 MG)
- SLT STRONG & MODERATE CYP3A4 INHIBITORS/CILOSTAZOL (<=50MG)
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.